Non-Animal Alternatives Testing Market Production Analysis, Advancement Strategy And Forecast To 2033

Global non-animal alternatives testing market size is expected to reach $3.63 Bn by 2028 at a rate of 11.8%, segmented as by technology, cell culture technology, high throughput technology, molecular imaging, omics technology

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


Non-Animal Alternatives Testing Market Production Analysis, Advancement Strategy And Forecast To 2033

Overview and Scope

The non-animal alternatives testing is testing products and services that do not involve testing on animals to determine the safety and efficacy of products and ingredients used in any industry sector. Non-animal alternative testing technologies include: in-vitro human cell and tissue cultures; organs-on-chips (OOCs); computer simulations and modelling (silico models); 3D bio-printing of tissues; and synthetic skin substitutes; as well as studies with human volunteers. These technologies replace animal testing in end-use industries including pharmaceuticals, medical devices, chemicals and pesticides, food, and others.

Sizing and Forecast

The non-animal alternatives testing market size has grown rapidly in recent years. It will grow from $2.08 billion in 2023 to $2.33 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%.  The growth in the historic period can be attributed to strong economic growth in emerging markets, the high costs of animal studies, the increasing adoption of in-vitro and in-silico technologies in basic research, the rising investments and the rise in research grants for developing alternative technologies and the increasing social awareness against animal cruelty.

The non-animal alternatives testing market size is expected to see rapid growth in the next few years. It will grow to $3.63 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%.  The growth in the forecast period can be attributed to government programs for non-animal alternative testing, the rise in the number of research and development activities and ethical concerns on animal experimentations will drive the growth. Major trends in the forecast period include focus on advancing ooc technology, focus on use of in silico trials, developing advanced 3d bio-printed organs and tissues, use of model organisms, collaborations and partnerships, and rising initiatives and grants to promote animal-free testing.

Order your report now for swift delivery, visit the link:

https://www.thebusinessresearchcompany.com/report/non-animal-alternatives-testing-global-market-report

Segmentation & Regional Insights

The non-animal alternatives testing market covered in this report is segmented –
1) By Technology: Cell Culture Technology, High Throughput Technology, Molecular Imaging, Omics Technology, Other Technologies

2) By Method: Cellular Assay, Biochemical Assay, In Silico, Ex-Vivo

3) By End-User: Pharmaceutical Industry, Cosmetics And Household Products, Diagnostics, Chemicals Industry, Food And Beverage Industry, Other End Users

North America was the largest region in the non-animal alternatives testing in 2023. Western Europe was the second-largest region in the non-animal alternatives testing market report. The regions covered in the non-animal alternatives testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2819&type=smp

Major Driver Impacting Market Growth

The support from the government and non-governmental organizations boosts the growth of the non-animal testing market. The government organizations enforce laws and regulations, raise funds to support non-animal testing methods such as tests on human volunteers, and advanced computer-modeling techniques, and also fund studies with human volunteers. In order to support non-animal testing, People for the Ethical Treatment of Animals (PETA) India, in 2022, announced a grant of 7 lakh rupees in order to advance animal-free methods for toxicology testing. Similar research programs to promote non-animal testing procedures are also initiated by countries such as Denmark, Brazil, Germany, Switzerland, Australia, China, and Korea. The constant support from the government drives the growth of the non-animal testing market.

Key Industry Players

Major companies operating in the non-animal alternatives testing market report are Evotec SE (Cyprotex), Bio-Rad Laboratories, Inc, BioIVT, Emulate, Inc, MatTek Corporation, SGS SA, Gentronix Limited, Promega Corporation, InSphero, VITROCELL Systems GmbH, Abbott India Limited, Becton Dickinson Private Limited, Biocartis Group NV, Bio-Techne India Private Limited, Danaher, Cleaver Scientific, China Tissue Engineering Co., Ltd. (J-TEC), Reprocell, Inc., Organ Technologies Co. Ltd, Mimetas, JRF Global, PharmaCo-Cell Company Ltd, Vessel Inc, Modulus Discovery, Sanofi, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Qiagen N.V, bioMérieux SA, QuantuMDx, Interlabservis, Roche Diagnostics, GeneMe, TestLine Clinical Diagnostics s.r.o, Thermo Fisher Scientific, PerkinElmer, GE Healthcare, Waters Corporation, Agilent Technologies, Bruker Corporation, Oxford Nanopore Technologies, 10x Genomics, Organovo Holdings, EMD Millipore, Cyprotex, RegeneMed Inc, HμREL Corporation, Nortis, In Silico Biosciences Inc, IOMICS Corporation, Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Inc., Cyagen Biosciences, Crown Biosciences, Harbour BioMed, Genewiz, Pacific Biosciences, Group 42 (G42) Healthcare, I-ONE, Wadi Jeddah Co, Philips, King Abdullah International Medical Research Center, Parexel, Soins Global, Pfizer South Africa, Dischem Pharmacy, Cipla Medpro South Africa Limited, Novartis South Africa, Synexa Life Sciences, IQVIA, Oceanic S. A, Hean

The non-animal alternatives testing market report table of contents includes:
1. Executive Summary

2. Market Characteristics

3. Market Trends And Strategies

4. Impact Of COVID-19

5. Market Size And Growth

6. Segmentation

7. Regional And Country Analysis

……….

27. Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions

29. Future Outlook and Potential Analysis

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info
Healthcare Blog: https://healthcareresearchreports.com
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model